0897.HK Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 08:38):

Stats
Šios dienos apimtis	100 068
Vidutinė apimtis	3.29M
Rinkos kapitalizacija	269.35M
EPS	HKD0 ( 2023-11-27 )
Last Dividend	HKD0.0508 ( 2014-07-21 )
Next Dividend	HKD0 ( N/A )
P/E	7.67
ATR14	HKD0 (0.00%)

Wai Yuen Tong Medicine Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Wai Yuen Tong Medicine Finansinės ataskaitos

Annual	2022
Pajamos:	HKD1.29B
Bruto pelnas:	HKD609.54M (47.38 %)
EPS:	HKD-0.0169

FY	2022
Pajamos:	HKD1.29B
Bruto pelnas:	HKD609.54M (47.38 %)
EPS:	HKD-0.0169

FY	2022
Pajamos:	HKD1.39B
Bruto pelnas:	HKD570.39M (40.99 %)
EPS:	HKD-0.0713

FY	2021
Pajamos:	HKD1.11B
Bruto pelnas:	HKD445.28M (40.17 %)
EPS:	HKD-0.305

Financial Reports:

No articles found.

Wai Yuen Tong Medicine Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Wai Yuen Tong Medicine Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 7.11 - good (71.07%) | Divividend Growth Potential Score: 3.20 - No dividend growth expected in the near future

Information

First Dividend	HKD0.0508	2011-08-03
Last Dividend	HKD0.0508	2014-07-21
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	HKD0.152	--
Avg. Dividend % Per Year	0.00%	--
Score	1.78	--
Div. Sustainability Score	7.11
Div.Growth Potential Score	3.20
Div. Directional Score	5.15	--

Next Divdend (Est)
(2025-10-21)

HKD0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

1.78

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2328.HK	Ex Dividend Knight	2023-06-26	Annually	0.00%
1299.HK	Ex Dividend Knight	2023-09-08	Semi-Annually	0.00%
0366.HK	Ex Dividend Knight	2023-09-25	Semi-Annually	0.00%
6119.HK	Ex Dividend Knight	2023-06-06	Annually	0.00%
1858.HK	Ex Dividend Junior	2023-06-30	Annually	0.00%
0882.HK	Ex Dividend Knight	2023-09-25	Semi-Annually	0.00%
0026.HK	Ex Dividend Junior	2023-10-03	Semi-Annually	0.00%
2682.HK	Ex Dividend Junior	2023-09-04	Annually	0.00%
1432.HK	Ex Dividend Junior	2023-06-19	Insufficient data to determine frequency	0.00%
0520.HK	Ex Dividend Junior	2023-10-05	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0268	1.500	9.46	10.00	[0 - 0.5]
returnOnAssetsTTM	0.00553	1.200	9.82	10.00	[0 - 0.3]
returnOnEquityTTM	0.0159	1.500	-0.934	-1.401	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.560	0.800	7.20	5.76	[1 - 3]
quickRatioTTM	0.477	0.800	-1.900	-1.520	[0.8 - 2.5]
cashRatioTTM	0.322	1.500	9.32	10.00	[0.2 - 2]
debtRatioTTM	0.229	-1.500	6.18	-9.27	[0 - 0.6]
interestCoverageTTM	0.993	1.000	-0.743	-0.743	[3 - 30]
operatingCashFlowPerShareTTM	0.136	2.00	9.95	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0857	2.00	9.96	10.00	[0 - 20]
debtEquityRatioTTM	0.677	-1.500	7.29	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.487	1.000	5.21	5.21	[0.2 - 0.8]
operatingProfitMarginTTM	0.0816	1.000	-0.368	-0.368	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.107	1.000	-0.516	-0.516	[0.2 - 2]
assetTurnoverTTM	0.206	0.800	-1.957	-1.566	[0.5 - 2]
Total Score				7.11

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	7.53	1.000	9.34	0	[1 - 100]
returnOnEquityTTM	0.0159	2.50	-0.601	-1.401	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0857	2.00	9.97	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.136	2.00	9.95	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0404	1.500	-3.60	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.119	1.000	9.53	0	[0.1 - 0.5]
Total Score				3.20

Wai Yuen Tong Medicine

Wai Yuen Tong Medicine Holdings Limited, an investment holding company, manufactures, processes, and retails traditional Chinese medicines, Western pharmaceutical products, and health food and personal products in Hong Kong, Mainland China, Macau, and internationally. The company offers Chinese medicines and health food products under the Wai Yuen Tong brand name; and Western pharmaceutical and personal care products under the Madame Pearl's and Pearl's brands. It also engages in the investment, holding, and selling of properties; provision of financial services; and agricultural produce exchange market operation. As of March 31, 2022, the company operated 63 retail stores in Hong Kong. The company was founded in 1897 and is headquartered in Kowloon Bay, Hong Kong. Wai Yuen Tong Medicine Holdings Limited is a subsidiary of Rich Time Strategy Limited.